ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney/pancreas transplantation"

  • 2022 American Transplant Congress

    Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience

    N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Weight gain is common following organ transplantation, and there exists concern that in simultaneous pancreas-kidney (SPK) recipients, this may lead to poorer graft outcomes.*Methods:…
  • 2022 American Transplant Congress

    Transplant Coordinator Time Saved (TCTS) Through a Hybrid On Call Team for Deceased Donor Kidney and Pancreas Transplant Organ Offers

    K. Ko, C. Gregory, J. Le, A. Lutrick, U. Reddy

    Division of Kidney and Pancreas Transplantation, UC Irvine, Orange, CA

    *Purpose: The purpose of this analysis was to estimate transplant coordinator time saved (TCTS) through the implementation of a hybrid on call team. Historically, transplant…
  • 2022 American Transplant Congress

    Everolimus versus Mycophenolate in Simultaneous Pancreas and Kidney Transplantation: Progression of Diabetic Retinopathy in a Prospective Randomized Trial

    B. Hagerf1, Z. Hladíková1, M. Zahradnická1, K. Kesslerová2, T. Sosna2, P. Girman1, F. Saudek1

    1Diabetes Centre, IKEM, Prague, Czech Republic, 2Ophtalmology Clinic, Thomayer Hospital, Prague, Czech Republic

    *Purpose: mTOR inhibitors are known for their antiangiogenic effect. We compared the impact of everolimus (E) and mycophenolic acid (MPA) on the course of diabetic…
  • 2022 American Transplant Congress

    Post-Transplant Lymphoproliferative Disorder in Kidney and Simultaneous Pancreas and Kidney Transplant Recipients Predictors, and Patient and Allograft Outcomes

    M. A. Mohamed1, E. A. Yousif1, V. Manchala2, F. Aziz3, N. Garg4, S. Parajuli4, D. Mandelbrot5, B. Astor1

    1Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Medicine-Transplant Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 3University of Wsiconsin, Madison, WI, 4University of Wisconsin, Madison, WI, 5UW Health, Madison, WI

    *Purpose: Post-transplant lymphoproliferative disorder (PTLD) is a devastating complication following kidney and pancreas transplantation. 12% of UNOS waitlisted candidates had previous transplant and 20% are…
  • 2022 American Transplant Congress

    Similar Outcomes in Type 2 Diabetic vs Type 1 Diabetics Receiving Simultaneous Kidney Pancreas Transplantation

    P. Budhiraja1, H. Me1, J. Ninan2, S. Reddy2, S. S. Misra1, R. Heilman1, H. Khamash1, K. Reddy1, C. Jadloweic1, N. Katariya1, H. Chakkera1

    1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic, Rochester, MN

    *Purpose: Combined kidney-pancreas transplant remains an optimal choice for type 1 diabetics with kidney failure. The benefit for those with type 2 diabetes, however, remains…
  • 2022 American Transplant Congress

    An Initial Analysis of Baseline Levels of Dd-cfdna After Pancreas Transplantation: A Prospective Study from High-Volume Centers in the United States

    A. Yoo1, I. Qian1, A. Riedel1, G. Kibria1, A. Bartosic1, R. Soltani2, O. Nduanya3, M. Omidi3, J. S. Odorico2, P. L. Abrams3, M. Cooper3, J. S. Bromberg1, J. R. Scalea1

    1University of Maryland School of Medicine, Baltimore, MD, 2University of Wisconsin School of Medicine, Madison, WI, 3Georgetown University School of Medicine, Washington, DC

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that prevents…
  • 2022 American Transplant Congress

    Is BK After SPK Okay?: Kidney and Pancreas Transplant Outcomes After BK Viremia

    G. Dube1, K. McCune2, D. Cohen3, L. Ratner2, S. Husain1

    1Columbia University Medical Center, New York, NY, 2Columbia University, New York, NY, 3Columbia University Med Ctr, New York, NY

    *Purpose: BK viremia and BK nephropathy (BKN) are common after kidney transplant alone, occurring in ~15% and ~1-10%, and are associated with an increased risk…
  • 2022 American Transplant Congress

    Survival Comparison of Simultaneous Pancreas-Kidney Transplant with Pancreas After Living-Donor Kidney Transplant by Wait Time and Organ Quality

    G. R. Lyden1, E. S. Helgeson2, E. B. Finger3, A. J. Matas3, J. J. Snyder4, D. M. Vock2

    1Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute; Division of Biostatistics, University of Minnesota, Mpls, MN, 2Div Biostatistics U MN, Mpls, MN, 3Dept Surg U MN, Mpls, MN, 4Hennepin Healthcare Research Institute, Mpls, MN

    *Purpose: The survival benefit of simultaneous pancreas-kidney (SPK) compared to pancreas after living-donor kidney (PALK) transplant is controversial. Wait times for SPK and donor risk…
  • 2022 American Transplant Congress

    Association of Physical Function and Depression Among Kidney-Pancreas Transplant Recipients Using PROMIS CATs

    A. Yantsis1, W. Ghazi1, A. Norgate1, M. Sanchez1, Y. Sun1, R. Gupta1, R. Ahuja1, I. Mucsi2

    1University Health Network, Toronto, ON, Canada, 2Toronto General Hospital, Toronto, ON, Canada

    *Purpose: The number of kidney-pancreas (KP) transplants is increasing accounting for approximately 6% of all kidney transplants in Canada. In addition to kidney failure and…
  • 2022 American Transplant Congress

    Three‐Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas‐Kidney Transplantation in Type 1 Diabetes Patients

    M. Ji1, S. Chang1, M. Wang1, K. Lentine2, M. Merzkani1, H. Murad1, M. M. Ibrahim1, M. Zayed1, J. Wellen1, S. Sutcliffe1, T. Alhamad1

    1Washington University in St. Louis, Saint Louis, MO, 2Saint Louis University, Saint Louis, MO

    *Purpose: Simultaneous pancreas-kidney transplantation (SPK) is the only persistently successful treatment option for patients with diabetes mellitus and end-stage renal disease. However, SPK carries a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences